Franck Rouby
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- CAR-T cell therapy research
- Toxicology top 10%
Papers in
- Oncology 7
- Cancer Immunotherapy and Biomarkers 6
-
- Immunodeficiency and Autoimmune Disorders 2
- Biosimilars and Bioanalytical Methods 2
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 1
- Co-authors
- Marion Sassier (6 shared papers)Joëlle Micallef (7 shared papers)Mathieu Puyade (2 shared papers)M. Martin (2 shared papers)Ghada Miremont‐Salamé (1 shared paper)Marie‐Christine Pérault‐Pochat (1 shared paper)Mélissa Yelehe‐Okouma (2 shared papers)Nadine Petitpain (2 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (1 paper)Drug and Alcohol Dependence (1 paper)British Journal of Clinical Pharmacology (1 paper)Cancers (1 paper)Neuromuscular Disorders (1 paper)
- Partner nations
- FranceNew ZealandSwitzerland
In The Last Decade
Franck Rouby
18 papers receiving 373 citations
Peers
Comparison fields: 5 of 62
- Oncology 202
- Toxicology 18
- Immunology 73
- Transplantation 7
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Franck Rouby
This map shows the geographic impact of Franck Rouby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franck Rouby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franck Rouby more than expected).
Fields of papers citing papers by Franck Rouby
This network shows the impact of papers produced by Franck Rouby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franck Rouby. The network helps show where Franck Rouby may publish in the future.
Co-authors
The 25 scholars most cited alongside Franck Rouby, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 88 | |
| 2 | 2019 | 54 | |
| 3 | 2018 | 41 | |
| 4 | 2019 | 36 | |
| 5 | 2018 | 27 | |
| 6 | 2021 | 24 | |
| 7 | 2010 | 23 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 16 | |
| 10 | 2018 | 11 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 8 | |
| 13 | 2021 | 6 | |
| 14 | 2022 | 5 | |
| 15 | 2020 | 4 | |
| 16 | 2008 | 4 | |
| 17 | 2019 | 3 | |
| 18 | 2008 | 3 |
About Franck Rouby
Franck Rouby is a scholar working on Oncology, Immunology, Infectious Diseases, Pharmacology and Neurology, having authored 18 papers that have together received 379 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Drug-Induced Adverse Reactions (3 papers), Pharmaceutical Economics and Policy (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Biosimilars and Bioanalytical Methods (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Diabetes and associated disorders (1 paper) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (1 paper). The work is most often cited by research in Oncology (202 citations), Toxicology (18 citations), Immunology (73 citations), Transplantation (7 citations) and Pulmonary and Respiratory Medicine (58 citations). Franck Rouby has collaborated with scholars based in France, New Zealand and Switzerland. Frequent co-authors include Marion Sassier, Joëlle Micallef, Mathieu Puyade, M. Martin, Ghada Miremont‐Salamé, Marie‐Christine Pérault‐Pochat, Mélissa Yelehe‐Okouma, Nadine Petitpain, Pierre Gillet and Marc Klein. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Drug and Alcohol Dependence, British Journal of Clinical Pharmacology, Cancers and Neuromuscular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.